Kazhila Croffat Chinsembu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kazhila Croffat Chinsembu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Adamson Sinjani Muula
Kamuzu University of Health Sciences
1 shared publication - Choshi D. Kasanda
University of Namibia, Namibia
1 shared publication - Cornelia N Shimwooshili-Shaimemanya
Department of Science, Mathematics and Sports Education, Faculty of Education, University of Namibia, P/B 13301, Windhoek, Namibia
1 shared publication - Donovan Zealand
Department of Science, Mathematics and Sports Education, Faculty of Education, University of Namibia, P/B 13301, Windhoek, Namibia
1 shared publication - Edet F. Archibong
Department of Pharmaceutical Sciences, School of Pharmacy, Faculty of Health Sciences and Veterinary Medicine, University of Namibia, P/Bag 13301, Windhoek, Namibia
1 shared publication Emmanuel Rudatsikira
Division of Epidemiology and Biostatistics, School of Public Health, San Diego State University
1 shared publication
Latest Publications
- 20 October 2022
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 101, 107779
A DFT and molecular docking study of xerantholide and its interaction with Neisseria gonorrhoeae carbonic anhydrase
- 20 October 2022
- Published by Elsevier in Computational Biology and Chemistry
- Vol. 101, 107779
A DFT and molecular docking study of xerantholide and its interaction with Neisseria gonorrhoeae carbonic anhydrase
- Open Access
- 7 May 2021
- Published by University of Namibia in International Science and Technology Journal of Namibia
- Vol. 14, 1-8
Phytomedicines and nutraceuticals in the clinical management of COVID-19
COVID-19 has exposed what we have long-feared: Many countries in Africa have very fragile public healthcare delivery systems, out-dated clinical laboratory infrastructure, and inadequate home-grown biomedical research preparedness. These challenges that are an asterisk in the prevention and treatment of COVID-19 in Africa should become the new window of opportunity for novel drugs from indigenous African medicinal plants. Africa needs a drug discovery renaissance inspired by the potentials of the continent’s huge endowment of medicinal plants. As a continent, Africa needs to invest in indigenous natural agents that inhibit entry of human coronavirus into cells. Africa should also develop natural products that block general replication and specific chymotrypsin-like protease-mediated replication of SARS-CoV-2. Turmeric, Eucalyptus essential oil, garlic, cinnamon plant, and Ganoderma mushroom are being used to offset the effects of COVID-19 in many parts of the world. Plant active compounds such as glycyrrhizin, iguesterin, resveratrol, homoharringtonine, tomentins A-E, sinigrin, silvestrol, and cinnamaldehyde have anti-COVID-19 actions. Due to current obstacles in the clinical management of COVID-19 in Africa, this paper advocates for the use of indigenous natural medicines to roll-back the pandemic.
- 7 May 2021
- Published by University of Namibia in International Science and Technology Journal of Namibia
- Vol. 14, 1-8
Open AccessPhytomedicines and nutraceuticals in the clinical management of COVID-19
COVID-19 has exposed what we have long-feared: Many countries in Africa have very fragile public healthcare delivery systems, out-dated clinical laboratory infrastructure, and inadequate home-grown biomedical research preparedness. These challenges that are an asterisk in the prevention and treatment of COVID-19 in Africa should become the new window of opportunity for novel drugs from indigenous African medicinal plants. Africa needs a drug discovery renaissance inspired by the potentials of the continent’s huge endowment of medicinal plants. As a continent, Africa needs to invest in indigenous natural agents that inhibit entry of human coronavirus into cells. Africa should also develop natural products that block general replication and specific chymotrypsin-like protease-mediated replication of SARS-CoV-2. Turmeric, Eucalyptus essential oil, garlic, cinnamon plant, and Ganoderma mushroom are being used to offset the effects of COVID-19 in many parts of the world. Plant active compounds such as glycyrrhizin, iguesterin, resveratrol, homoharringtonine, tomentins A-E, sinigrin, silvestrol, and cinnamaldehyde have anti-COVID-19 actions. Due to current obstacles in the clinical management of COVID-19 in Africa, this paper advocates for the use of indigenous natural medicines to roll-back the pandemic.
- Open Access
- 6 October 2020
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 30 (5) , 603-621
Coronaviruses and Nature’s Pharmacy for the Relief of Coronavirus Disease 2019
- 6 October 2020
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 30 (5) , 603-621
Open AccessCoronaviruses and Nature’s Pharmacy for the Relief of Coronavirus Disease 2019
- Open Access
‘Poisoned Chalice’: Law on Access to Biological and Genetic Resources and Associated Traditional Knowledge in Namibia
Many countries in Africa provide ethnobiological resources (more especially ethnomedicinal plants), which are converted by companies and users from developed countries into biopharmaceutical products without any monetary benefits to the countries of origin. To mitigate the lack of benefits, African countries are beginning to enact access and benefit-sharing (ABS) legislation, though their wheels turn very slowly. Since many African ABS laws have not been appraised for their feasibility, this paper presents a contextual analysis of Namibia’s new ABS law: The Access to Biological and Genetic Resources and Associated Traditional Knowledge Act No. 2 of 27 June 2017. Even if several international conventions on ABS and local institutional structures guided the evolution of the 2017 Act, the main drivers for the enactment of the ABS legislation in Namibia are: Inequitable sharing of monetary benefits from the green economy, putative, but unproven cases of biopiracy, and political power contestations over ethnobiological resources. A critical analysis of important challenges faced by Namibia’s new ABS law include: Lack of adequate participatory consultations and technical capacity at the local level, discount of the non-commodity cultural value of TK, ambiguous and narrow definition of the term ‘community’, lack of a clause on confidentiality, and assertions that the new ABS law negatively impacts research in Namibian universities and botanic gardens. In contrast to South Africa’s ABS law, Namibia’s law is more onerous because it does not differentiate between commercial and non-commercial research.
Open Access‘Poisoned Chalice’: Law on Access to Biological and Genetic Resources and Associated Traditional Knowledge in Namibia
Many countries in Africa provide ethnobiological resources (more especially ethnomedicinal plants), which are converted by companies and users from developed countries into biopharmaceutical products without any monetary benefits to the countries of origin. To mitigate the lack of benefits, African countries are beginning to enact access and benefit-sharing (ABS) legislation, though their wheels turn very slowly. Since many African ABS laws have not been appraised for their feasibility, this paper presents a contextual analysis of Namibia’s new ABS law: The Access to Biological and Genetic Resources and Associated Traditional Knowledge Act No. 2 of 27 June 2017. Even if several international conventions on ABS and local institutional structures guided the evolution of the 2017 Act, the main drivers for the enactment of the ABS legislation in Namibia are: Inequitable sharing of monetary benefits from the green economy, putative, but unproven cases of biopiracy, and political power contestations over ethnobiological resources. A critical analysis of important challenges faced by Namibia’s new ABS law include: Lack of adequate participatory consultations and technical capacity at the local level, discount of the non-commodity cultural value of TK, ambiguous and narrow definition of the term ‘community’, lack of a clause on confidentiality, and assertions that the new ABS law negatively impacts research in Namibian universities and botanic gardens. In contrast to South Africa’s ABS law, Namibia’s law is more onerous because it does not differentiate between commercial and non-commercial research.
- Open Access
- 1 July 2019
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 29 (4) , 504-528
Chemical diversity and activity profiles of HIV-1 reverse transcriptase inhibitors from plants
- 1 July 2019
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 29 (4) , 504-528
Open AccessChemical diversity and activity profiles of HIV-1 reverse transcriptase inhibitors from plants
- 1 February 2016
- Published by Elsevier in Acta Tropica
- Vol. 154, 6-18
Plants and other natural products used in the management of oral infections and improvement of oral health
- 1 February 2016
- Published by Elsevier in Acta Tropica
- Vol. 154, 6-18
Plants and other natural products used in the management of oral infections and improvement of oral health
- Open Access
- 1 January 2016
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2016 (1) , 4238625
Ethnobotanical Study of Plants Used in the Management of HIV/AIDS‐Related Diseases in Livingstone, Southern Province, Zambia
Faced with critical shortages of staff, long queues, and stigma at public health facilities in Livingstone, Zambia, persons who suffer from HIV/AIDS‐related diseases use medicinal plants to manage skin infections, diarrhoea, sexually transmitted infections, tuberculosis, cough, malaria, and oral infections. In all, 94 medicinal plant species were used to manage HIV/AIDS‐related diseases. Most remedies are prepared from plants of various families such as Combretaceae, Euphorbiaceae, Fabaceae, and Lamiaceae. More than two‐thirds of the plants (mostly leaves and roots) are utilized to treat two or more diseases related to HIV infection. Eighteen plants, namely, Achyranthes aspera L., Lannea discolor (Sond.) Engl., Hyphaene petersiana Klotzsch ex Mart., Asparagus racemosus Willd., Capparis tomentosa Lam., Cleome hirta Oliv., Garcinia livingstonei T. Anderson, Euclea divinorum Hiern, Bridelia cathartica G. Bertol., Acacia nilotica Delile, Piliostigma thonningii (Schumach.) Milne‐Redh., Dichrostachys cinerea (L.) Wight and Arn., Abrus precatorius L., Hoslundia opposita Vahl., Clerodendrum capitatum (Willd.) Schumach., Ficus sycomorus L., Ximenia americana L., and Ziziphus mucronata Willd., were used to treat four or more disease conditions. About 31% of the plants in this study were administered as monotherapies. Multiuse medicinal plants may contain broad‐spectrum antimicrobial agents. However, since widely used plants easily succumb to the threats of overharvesting, they need special protocols and guidelines for their genetic conservation. There is still need to confirm the antimicrobial efficacies, pharmacological parameters, cytotoxicity, and active chemical ingredients of the discovered plants.
- 1 January 2016
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2016 (1) , 4238625
Open AccessEthnobotanical Study of Plants Used in the Management of HIV/AIDS‐Related Diseases in Livingstone, Southern Province, Zambia
Faced with critical shortages of staff, long queues, and stigma at public health facilities in Livingstone, Zambia, persons who suffer from HIV/AIDS‐related diseases use medicinal plants to manage skin infections, diarrhoea, sexually transmitted infections, tuberculosis, cough, malaria, and oral infections. In all, 94 medicinal plant species were used to manage HIV/AIDS‐related diseases. Most remedies are prepared from plants of various families such as Combretaceae, Euphorbiaceae, Fabaceae, and Lamiaceae. More than two‐thirds of the plants (mostly leaves and roots) are utilized to treat two or more diseases related to HIV infection. Eighteen plants, namely, Achyranthes aspera L., Lannea discolor (Sond.) Engl., Hyphaene petersiana Klotzsch ex Mart., Asparagus racemosus Willd., Capparis tomentosa Lam., Cleome hirta Oliv., Garcinia livingstonei T. Anderson, Euclea divinorum Hiern, Bridelia cathartica G. Bertol., Acacia nilotica Delile, Piliostigma thonningii (Schumach.) Milne‐Redh., Dichrostachys cinerea (L.) Wight and Arn., Abrus precatorius L., Hoslundia opposita Vahl., Clerodendrum capitatum (Willd.) Schumach., Ficus sycomorus L., Ximenia americana L., and Ziziphus mucronata Willd., were used to treat four or more disease conditions. About 31% of the plants in this study were administered as monotherapies. Multiuse medicinal plants may contain broad‐spectrum antimicrobial agents. However, since widely used plants easily succumb to the threats of overharvesting, they need special protocols and guidelines for their genetic conservation. There is still need to confirm the antimicrobial efficacies, pharmacological parameters, cytotoxicity, and active chemical ingredients of the discovered plants.
- Open Access
- 9 June 2011
- Published by Springer Nature in Journal of Ethnobiology and Ethnomedicine
- Vol. 7 (1) , 17
Indigenous knowledge of HIV/AIDS among High School students in Namibia
Background: The use of Indigenous Knowledge (IK) can help students to form schemas for interpreting local phenomena through the prism of what they already know. The formation of schemas related to HIV/AIDS risk perception and prevention is important for individuals to form local meanings of the HIV/AIDS epidemic. The objective of this study was to explore the indigenous names and symptoms of HIV/AIDS among High School students in Namibia Methods: Focus group discussions were used to collect qualitative data on indigenous names and symptoms of HIV/AIDS from students in 18 secondary schools located in six education regions. Data were grouped into themes. Results: People living with HIV/AIDS were called names meaning prostitute: ihule, butuku bwa sihule, and shikumbu. Names such askibutu bwa masapo (bone disease),katjumba (a young child),kakithi (disease), andshinangele (very thin person) were used to describe AIDS. Derogatory names like mbwa (dog), esingahogo (pretender), ekifi (disease), and shinyakwi noyana (useless person) were also used. Other terms connoted death (zeguru, heaven; omudimba, corpse), fear (simbandembande, fish eagle; katanga kamufifi, (hot ball), and subtle meaning using slang words such as 4 × 4, oondanda ne (four letters), desert soul, and mapilelo (an AIDS service organization). Typical (body wasting) and non-typical (big head, red eyes) symptoms of HIV were also revealed. Conclusions: The study determined students' IK of the names and symptoms of HIV/AIDS. Programmes to prevent/manage adolescent HIV infection and stigma may be strengthened if they take students' indigenous understandings of the disease on board.
- 9 June 2011
- Published by Springer Nature in Journal of Ethnobiology and Ethnomedicine
- Vol. 7 (1) , 17
Open AccessIndigenous knowledge of HIV/AIDS among High School students in Namibia
Background: The use of Indigenous Knowledge (IK) can help students to form schemas for interpreting local phenomena through the prism of what they already know. The formation of schemas related to HIV/AIDS risk perception and prevention is important for individuals to form local meanings of the HIV/AIDS epidemic. The objective of this study was to explore the indigenous names and symptoms of HIV/AIDS among High School students in Namibia Methods: Focus group discussions were used to collect qualitative data on indigenous names and symptoms of HIV/AIDS from students in 18 secondary schools located in six education regions. Data were grouped into themes. Results: People living with HIV/AIDS were called names meaning prostitute: ihule, butuku bwa sihule, and shikumbu. Names such askibutu bwa masapo (bone disease),katjumba (a young child),kakithi (disease), andshinangele (very thin person) were used to describe AIDS. Derogatory names like mbwa (dog), esingahogo (pretender), ekifi (disease), and shinyakwi noyana (useless person) were also used. Other terms connoted death (zeguru, heaven; omudimba, corpse), fear (simbandembande, fish eagle; katanga kamufifi, (hot ball), and subtle meaning using slang words such as 4 × 4, oondanda ne (four letters), desert soul, and mapilelo (an AIDS service organization). Typical (body wasting) and non-typical (big head, red eyes) symptoms of HIV were also revealed. Conclusions: The study determined students' IK of the names and symptoms of HIV/AIDS. Programmes to prevent/manage adolescent HIV infection and stigma may be strengthened if they take students' indigenous understandings of the disease on board.
- Open Access
- 11 September 2010
- Published by Springer Nature in Journal of Ethnobiology and Ethnomedicine
- Vol. 6 (1) , 25
An ethnobotanical survey of plants used to manage HIV/AIDS opportunistic infections in Katima Mulilo, Caprivi region, Namibia
Katima Mulilo has the highest burden of HIV/AIDS in Namibia. Due to several constraints of the antiretroviral therapy programme, HIV-infected persons still use ethnomedicines to manage AIDS-related opportunistic infections. Despite the reliance on plants to manage HIV/AIDS in Katima Mulilo, there have been no empirical studies to document the specific plant species used by traditional healers to treat AIDS-related opportunistic infections. In this study, an ethnobotanical survey was conducted to record the various plant families, species, and plant parts used to manage different HIV/AIDS-related opportunistic infections in Katima Mulilo, Caprivi region, Namibia. The results showed that a total of 71 plant species from 28 families, mostly the Combretaceae (14%), Anacardiaceae (8%), Mimosaceae (8%), and Ebanaceae (7%), were used to treat conditions such as herpes zoster, diarrhoea, coughing, malaria, meningitis, and tuberculosis. The most plant parts used were leaves (33%), bark (32%), and roots (28%) while the least used plant parts were fruits/seeds (4%). Further research is needed to isolate the plants' active chemical compounds and understand their modes of action.
- 11 September 2010
- Published by Springer Nature in Journal of Ethnobiology and Ethnomedicine
- Vol. 6 (1) , 25
Open AccessAn ethnobotanical survey of plants used to manage HIV/AIDS opportunistic infections in Katima Mulilo, Caprivi region, Namibia
Katima Mulilo has the highest burden of HIV/AIDS in Namibia. Due to several constraints of the antiretroviral therapy programme, HIV-infected persons still use ethnomedicines to manage AIDS-related opportunistic infections. Despite the reliance on plants to manage HIV/AIDS in Katima Mulilo, there have been no empirical studies to document the specific plant species used by traditional healers to treat AIDS-related opportunistic infections. In this study, an ethnobotanical survey was conducted to record the various plant families, species, and plant parts used to manage different HIV/AIDS-related opportunistic infections in Katima Mulilo, Caprivi region, Namibia. The results showed that a total of 71 plant species from 28 families, mostly the Combretaceae (14%), Anacardiaceae (8%), Mimosaceae (8%), and Ebanaceae (7%), were used to treat conditions such as herpes zoster, diarrhoea, coughing, malaria, meningitis, and tuberculosis. The most plant parts used were leaves (33%), bark (32%), and roots (28%) while the least used plant parts were fruits/seeds (4%). Further research is needed to isolate the plants' active chemical compounds and understand their modes of action.
- Open Access
- 23 October 2009
- Published by Springer Nature in Journal of Ethnobiology and Ethnomedicine
- Vol. 5 (1) , 30
Model and experiences of initiating collaboration with traditional healers in validation of ethnomedicines for HIV/AIDS in Namibia
Many people with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) in Namibia have access to antiretroviral drugs but some still use traditional medicines to treat opportunistic infections and offset side-effects from antiretroviral medication. Namibia has a rich biodiversity of indigenous plants that could contain novel anti-HIV agents. However, such medicinal plants have not been identified and properly documented. Various ethnomedicines used to treat HIV/AIDS opportunistic infections have not been scientifically validated for safety and efficacy. These limitations are mostly attributable to the lack of collaboration between biomedical scientists and traditional healers. This paper presents a five-step contextual model for initiating collaboration with Namibian traditional healers in order that candidate plants that may contain novel anti-HIV agents are identified, and traditional medicines used to treat HIV/AIDS opportunistic infections are subjected to scientific validation. The model includes key structures and processes used to initiate collaboration with traditional healers in Namibia; namely, the National Biosciences Forum, a steering committee with the University of Namibia (UNAM) as the focal point, a study tour to Zambia and South Africa where other collaborative frameworks were examined, commemorations of the African Traditional Medicine Day (ATMD), and consultations with stakeholders in north-eastern Namibia. Experiences from these structures and processes are discussed. All traditional healers in north-eastern Namibia were willing to collaborate with UNAM in order that their traditional medicines could be subjected to scientific validation. The current study provides a framework for future collaboration with traditional healers and the selection of candidate anti-HIV medicinal plants and ethnomedicines for scientific testing in Namibia.
- 23 October 2009
- Published by Springer Nature in Journal of Ethnobiology and Ethnomedicine
- Vol. 5 (1) , 30
Open AccessModel and experiences of initiating collaboration with traditional healers in validation of ethnomedicines for HIV/AIDS in Namibia
Many people with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome (HIV/AIDS) in Namibia have access to antiretroviral drugs but some still use traditional medicines to treat opportunistic infections and offset side-effects from antiretroviral medication. Namibia has a rich biodiversity of indigenous plants that could contain novel anti-HIV agents. However, such medicinal plants have not been identified and properly documented. Various ethnomedicines used to treat HIV/AIDS opportunistic infections have not been scientifically validated for safety and efficacy. These limitations are mostly attributable to the lack of collaboration between biomedical scientists and traditional healers. This paper presents a five-step contextual model for initiating collaboration with Namibian traditional healers in order that candidate plants that may contain novel anti-HIV agents are identified, and traditional medicines used to treat HIV/AIDS opportunistic infections are subjected to scientific validation. The model includes key structures and processes used to initiate collaboration with traditional healers in Namibia; namely, the National Biosciences Forum, a steering committee with the University of Namibia (UNAM) as the focal point, a study tour to Zambia and South Africa where other collaborative frameworks were examined, commemorations of the African Traditional Medicine Day (ATMD), and consultations with stakeholders in north-eastern Namibia. Experiences from these structures and processes are discussed. All traditional healers in north-eastern Namibia were willing to collaborate with UNAM in order that their traditional medicines could be subjected to scientific validation. The current study provides a framework for future collaboration with traditional healers and the selection of candidate anti-HIV medicinal plants and ethnomedicines for scientific testing in Namibia.